(Q46970965)

27 December 2017

title

Effect of antipsychotics on creatine kinase activity in rat brain (English)

1 reference

27 December 2017

author

Giselli Scaini

2

1 reference

27 December 2017

Emilio L Streck

6

1 reference

27 December 2017

João Quevedo

7

1 reference

27 December 2017

Clarissa M Comim

5

object named as

Clarissa M Comim

1 reference

27 December 2017

Priscila B Di-Pietro

3

object named as

Priscila B Di-Pietro

1 reference

27 December 2017

author name string

Lara C Assis

1

1 reference

27 December 2017

Adalberto A Castro

4

1 reference

27 December 2017

publication date

1 November 2007

1 reference

27 December 2017

Basic and Clinical Pharmacology and Toxicology

published in

1 reference

27 December 2017

volume

101

1 reference

27 December 2017

issue

5

1 reference

27 December 2017

page(s)

315-319

1 reference

27 December 2017

Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7835.2007.00128.X

Oxidative modification of creatine kinase BB in Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7835.2007.00128.X

Abnormal properties of creatine kinase in Alzheimer's disease brain: correlation of reduced enzyme activity and active site photolabeling with aberrant cytosol-membrane partitioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7835.2007.00128.X

Effects of lithium and valproate on hippocampus citrate synthase activity in an animal model of mania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7835.2007.00128.X

Nitric oxide inhibits creatine kinase and regulates rat heart contractile reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7835.2007.00128.X

Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7835.2007.00128.X

Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7835.2007.00128.X

Mitochondrial dysfunction in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7835.2007.00128.X

Molecular evidence for mitochondrial dysfunction in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7835.2007.00128.X

Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7835.2007.00128.X

Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7835.2007.00128.X

Conventional antipsychotic medications for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7835.2007.00128.X

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7835.2007.00128.X

Does cognitive function improve with quetiapine in comparison to haloperidol?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7835.2007.00128.X

Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7835.2007.00128.X

Haloperidol- and clozapine-induced oxidative stress in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7835.2007.00128.X

Haloperidol and clozapine, but not olanzapine, induces oxidative stress in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7835.2007.00128.X

The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7835.2007.00128.X

Octamer formation and coupling of cardiac sarcomeric mitochondrial creatine kinase are mediated by charged N-terminal residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7835.2007.00128.X

Octamers of mitochondrial creatine kinase isoenzymes differ in stability and membrane binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7835.2007.00128.X

Protein thiol oxidation by haloperidol results in inhibition of mitochondrial complex I in brain regions: comparison with atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7835.2007.00128.X

Nitric oxide, superoxide, and hydrogen peroxide production in brain mitochondria after haloperidol treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7835.2007.00128.X

Neuroimaging studies of the cerebellum: language, learning and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7835.2007.00128.X

The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7835.2007.00128.X

Structural and behavioural consequences of double deficiency for creatine kinases BCK and UbCKmit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7835.2007.00128.X

Creatine kinase B-driven energy transfer in the brain is important for habituation and spatial learning behaviour, mossy fibre field size and determination of seizure susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7835.2007.00128.X

Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7835.2007.00128.X

10.1111/J.1742-7835.2007.00128.X

21 January 2018

Identifiers

DOI

1 reference

27 December 2017

1 reference

27 December 2017